Live
Ifilm App Android
فارسی عربي

Tourism

Real story behind ifilm weekend movie

The Sinister Mind’, directed by Mehrdad Khoshbakht, aired on Saturday, has depicted a sinister plan to assassinate an Iranian nuclear scientist.

Here are some facts about how the Israeli spy agency, Mossad, sponsored the real terrors back in January 2010.

At 6:30 on Sunday, January 12, 2010, professor Masoud Alimohammadi, Iranian nuclear scientist and a lecturer and faculty member at the University of Tehran, was assassinated by terrorists in north of Tehran.

Arieh Daad, member of Israeli parliament (Knesset), had said weeks before the terror attack that the Zionist regime had arrived on agreements with different people, including the MKO terrorist group, to what he had described as ‘make a heavy blow on Iran’.

The terror gang’s leader, who admitted that his gang had been trained and sponsored by the Zionist regime’s Mossad spy agency inside Zionist occupied territories, got up at 4 and parked his motorbike near a tree, next to martyr Alimohammadi’s house.

The martyr’s wife, who was witness to the explosion, later on said that she heard the blast immediately after she said goodbye to her husband and closed the door.

The terrorists all admitted that they had been trained in Israel. The training included military skills, motorbike riding, shooting, and self defense, as well as intelligence skills.

They had focused on bomb-making and detonation skills, to be able to produce and attach the bomb to the terror target’s car.

One of the terrorists, who was arrested, said he was sure the US was behind the Israeli-sponsored plot.

The terror gang’s leader admitted that Israel was afraid of Iran’s nuclear development, not the nuclear bomb.

The terrorists’ confessions also showed that they had been promised to be financially supported after the terror operation, and that they would be helped to flee Iran afterwards.

There have been other terror attacks against Iran nuclear scientists by the US and Israel. Get back here for the second part of our review, next week.

MF/MG

Share